Global Sartans Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types, and Application

Published On: Apr 2020

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 128889

Summary

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Sartans market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Sartans industry.

Based on our recent survey, we have several different scenarios about the Sartans YoY growth rate for 2020. The probable scenario is expected to grow by a -3.4% in 2020 and the revenue will be US$ 25.0 billion in 2020 from US$ 25.9 billion in 2019. The market size of Sartans will reach US$ 27.2 billion in 2026, with a CAGR of 1.2% from 2020 to 2026.

Sartans are the latest generation of antihypertensive drugs, which have good antihypertensive effect and drug tolerance, less adverse reactions, and have protective effect on target organs, so they are widely used in clinic. There are more than 1 billion patients with hypertension in the world. Long term treatment drives the demand for Sartans and intermediates. Due to the shortage of key intermediates, the tightening of environmental protection and the incident of Sartan impurities, the supply of Sartan products is in short supply and the price continues to rise.

The Sartans can be divided into five categories: Valsartan, Irbesartan, Telmisartan, Losartan and Others. Accordingly, the global market size of Valsartan, Irbesartan, Telmisartan, Losartan and Others will reach US $ xx billion, US $ xx billion, US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx%, xx%, xx% and xx%. Valsartan takes a big amount of market with xx%.

Valsartan

Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination valsartan/hydrochlorothiazide, valsartan/amlodipine, valsartan/amlodipine/hydrochlorothiazide, or valsartan/sacubitril.

Irbesartan

Irbesartan, sold under the brand name Avapro among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.

Telmisartan

Telmisartan, sold under the trade name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination telmisartan/hydrochlorothiazide and telmisartan/amlodipine.

Losartan

Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. It is also used for diabetic kidney disease, heart failure, and left ventricular enlargement. It is taken by mouth. It may be used alone or in addition to other blood pressure medication. Up to six weeks may be required for the full effects to occur.

Others

The other sartans contain Azilsartan, Olmesartan, Candesartan, etc.

From the perspective of application, Sartans can be divided into three main categories: Anti-Hypertension, Anti-Viral and Others. Accordingly, the global market size of Anti-Hypertension, Anti-Viral and Others will reach US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx% and xx%. Anti-Hypertension takes a big amount of market with xx%.

Anti-Hypertension

Hypertension is one of the most common chronic diseases, and it is also the main risk factor to induce various cardiovascular and cerebrovascular diseases. There are more than 1 billion hypertensive patients in the world, and about 270 million hypertensive adults in China. The treatment of chronic hypertension requires long-term medication, and the huge patient base and long-term treatment demand drive the continuous expansion of the market of antihypertensive drug raw materials and preparations.

Anti-Viral

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Sartans are also used in the antiviral field, among which the more widely used is the treatment of AIDS.

Others

Other applications of Sartans are Anti-Asthma, Anti-Cardiovascular, Anti-Kidney, etc.

The research report studies the Sartans market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.Source: Secondary Sources, Expert Interviews

Global Sartans market: Drivers and Restraints

This section covers the various factors driving the global Sartans market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by revenue and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.

Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.

Global Sartans market: Segment Analysis

The global Sartans market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue and sales for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided sales according to the consumption of the product.

Global Sartans market: Regional Analysis

The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Global Sartans market: Key Players

The report lists the major manufacturers in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

By the product type, the market is primarily split into

Valsartan

Telmisartan

Losartan

Irbesartan

Azilsartan

Olmesartan

By the end users/application, this report covers the following segments

Hypertension

Cardiovascular Diseases

Kidney Diseases

Other

Competitive Landscape:

The report provides a list of all the key players in the Sartans market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.

The Sartans key manufacturers in this market include:

Pfizer

Novartis

Merck

Astra Zeneca

Jhonson and Johnson

Eli Lilly

Sanofi

Bristol-Myers Squibb

Bayer

GSK

Teva Pharmaceutical

Table of Contents



1 Sartans Market Overview

1.1 Sartans Product Overview

1.2 Sartans Market Segment by Type

1.2.1 Valsartan

1.2.2 Telmisartan

1.2.3 Losartan

1.2.4 Irbesartan

1.2.5 Azilsartan

1.2.6 Olmesartan

1.3 Global Sartans Market Size by Type (2015-2026)

1.3.1 Global Sartans Market Size Overview by Type (2015-2026)

1.3.2 Global Sartans Historic Market Size Review by Type (2015-2020)

1.3.2.1 Global Sartans Sales Market Share Breakdown by Type (2015-2026)

1.3.2.2 Global Sartans Revenue Market Share Breakdown by Type (2015-2026)

1.3.2.3 Global Sartans Average Selling Price (ASP) by Type (2015-2026)

1.3.3 Global Sartans Market Size Forecast by Type (2021-2026)

1.3.3.1 Global Sartans Sales Market Share Breakdown by Application (2021-2026)

1.3.3.2 Global Sartans Revenue Market Share Breakdown by Application (2021-2026)

1.3.3.3 Global Sartans Average Selling Price (ASP) by Application (2021-2026)

1.4 Key Regions Market Size Segment by Type (2015-2020)

1.4.1 North America Sartans Sales Breakdown by Type (2015-2026)

1.4.2 Europe Sartans Sales Breakdown by Type (2015-2026)

1.4.3 Asia-Pacific Sartans Sales Breakdown by Type (2015-2026)

1.4.4 Latin America Sartans Sales Breakdown by Type (2015-2026)

1.4.5 Middle East and Africa Sartans Sales Breakdown by Type (2015-2026)



2 Global Sartans Market Competition by Company

2.1 Global Top Players by Sartans Sales (2015-2020)

2.2 Global Top Players by Sartans Revenue (2015-2020)

2.3 Global Top Players Sartans Average Selling Price (ASP) (2015-2020)

2.4 Global Top Manufacturers Sartans Manufacturing Base Distribution, Sales Area, Product Type

2.5 Sartans Market Competitive Situation and Trends

2.5.1 Sartans Market Concentration Rate (2015-2020)

2.5.2 Global 5 and 10 Largest Manufacturers by Sartans Sales and Revenue in 2019

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sartans as of 2019)

2.7 Date of Key Manufacturers Enter into Sartans Market

2.8 Key Manufacturers Sartans Product Offered

2.9 Mergers & Acquisitions, Expansion



3 Global Sartans Status and Outlook by Region (2015-2026)

3.1 Global Sartans Market Size and CAGR by Region: 2015 VS 2020 VS 2026

3.2 Global Sartans Market Size Market Share by Region (2015-2020)

3.2.1 Global Sartans Sales Market Share by Region (2015-2020)

3.2.2 Global Sartans Revenue Market Share by Region (2015-2020)

3.2.3 Global Sartans Sales, Revenue, Price and Gross Margin (2015-2020)

3.3 Global Sartans Market Size Market Share by Region (2021-2026)

3.3.1 Global Sartans Sales Market Share by Region (2021-2026)

3.3.2 Global Sartans Revenue Market Share by Region (2021-2026)

3.3.3 Global Sartans Sales, Revenue, Price and Gross Margin (2021-2026)

3.4 North America Sartans Market Size YoY Growth (2015-2026)

3.4.1 North America Sartans Revenue YoY Growth (2015-2026)

3.4.2 North America Sartans Sales YoY Growth (2015-2026)

3.5 Asia-Pacific Sartans Market Size YoY Growth (2015-2026)

3.5.1 Asia-Pacific Sartans Revenue YoY Growth (2015-2026)

3.5.2 Asia-Pacific Sartans Sales YoY Growth (2015-2026)

3.6 Europe Sartans Market Size YoY Growth (2015-2026)

3.6.1 Europe Sartans Revenue YoY Growth (2015-2026)

3.6.2 Europe Sartans Sales YoY Growth (2015-2026)

3.7 Latin America Sartans Market Size YoY Growth (2015-2026)

3.7.1 Latin America Sartans Revenue YoY Growth (2015-2026)

3.7.2 Latin America Sartans Sales YoY Growth (2015-2026)

3.8 Middle East and Africa Sartans Market Size YoY Growth (2015-2026)

3.8.1 Middle East and Africa Sartans Revenue YoY Growth (2015-2026)

3.8.2 Middle East and Africa Sartans Sales YoY Growth (2015-2026)



4 Global Sartans by Application

4.1 Sartans Segment by Application

4.1.1 Hypertension

4.1.2 Cardiovascular Diseases

4.1.3 Kidney Diseases

4.1.4 Other

4.2 Global Sartans Sales by Application: 2015 VS 2020 VS 2026

4.3 Global Sartans Historic Sales by Application (2015-2020)

4.4 Global Sartans Forecasted Sales by Application (2021-2026)

4.5 Key Regions Sartans Market Size by Application

4.5.1 North America Sartans by Application

4.5.2 Europe Sartans by Application

4.5.3 Asia-Pacific Sartans by Application

4.5.4 Latin America Sartans by Application

4.5.5 Middle East and Africa Sartans by Application

5 North America Sartans Market Size by Country (2015-2026)

5.1 North America Market Size Market Share by Country (2015-2020)

5.1.1 North America Sartans Sales Market Share by Country (2015-2020)

5.1.2 North America Sartans Revenue Market Share by Country (2015-2020)

5.2 North America Market Size Market Share by Country (2021-2026)

5.2.1 North America Sartans Sales Market Share by Country (2021-2026)

5.2.2 North America Sartans Revenue Market Share by Country (2021-2026)

5.3 North America Market Size YoY Growth by Country

5.3.1 U.S. Sartans Market Size YoY Growth (2015-2026)

5.3.2 Canada Sartans Market Size YoY Growth (2015-2026)

6 Europe Sartans Market Size by Country (2015-2026)

6.1 Europe Market Size Market Share by Country (2015-2020)

6.1.1 Europe Sartans Sales Market Share by Country (2015-2020)

6.1.2 Europe Sartans Revenue Market Share by Country (2015-2020)

6.2 Europe Market Size Market Share by Country (2021-2026)

6.2.1 Europe Sartans Sales Market Share by Country (2021-2026)

6.2.2 Europe Sartans Revenue Market Share by Country (2021-2026)

6.3 Europe Market Size YoY Growth by Country

6.3.1 Germany Sartans Market Size YoY Growth (2015-2026)

6.3.2 France Sartans Market Size YoY Growth (2015-2026)

6.3.3 U.K. Sartans Market Size YoY Growth (2015-2026)

6.3.4 Italy Sartans Market Size YoY Growth (2015-2026)

6.3.5 Russia Sartans Market Size YoY Growth (2015-2026)

7 Asia-Pacific Sartans Market Size by Country (2015-2026)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)

7.1.1 Asia-Pacific Sartans Sales Market Share by Country (2015-2020)

7.1.2 Asia-Pacific Sartans Revenue Market Share by Country (2015-2020)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)

7.2.1 Asia-Pacific Sartans Sales Market Share by Country (2021-2026)

7.2.2 Asia-Pacific Sartans Revenue Market Share by Country (2021-2026)

7.3 Asia-Pacific Market Size YoY Growth by Country

7.3.1 China Sartans Market Size YoY Growth (2015-2026)

7.3.2 Japan Sartans Market Size YoY Growth (2015-2026)

7.3.3 South Korea Sartans Market Size YoY Growth (2015-2026)

7.3.4 India Sartans Market Size YoY Growth (2015-2026)

7.3.5 Australia Sartans Market Size YoY Growth (2015-2026)

7.3.6 Taiwan Sartans Market Size YoY Growth (2015-2026)

7.3.7 Indonesia Sartans Market Size YoY Growth (2015-2026)

7.3.8 Thailand Sartans Market Size YoY Growth (2015-2026)

7.3.9 Malaysia Sartans Market Size YoY Growth (2015-2026)

7.3.10 Philippines Sartans Market Size YoY Growth (2015-2026)

7.3.11 Vietnam Sartans Market Size YoY Growth (2015-2026)

8 Latin America Sartans Market Size by Country (2015-2026)

8.1 Latin America Market Size Market Share by Country (2015-2020)

8.1.1 Latin America Sartans Sales Market Share by Country (2015-2020)

8.1.2 Latin America Sartans Revenue Market Share by Country (2015-2020)

8.2 Latin America Market Size Market Share by Country (2021-2026)

8.2.1 Latin America Sartans Sales Market Share by Country (2021-2026)

8.2.2 Latin America Sartans Revenue Market Share by Country (2021-2026)

8.3 Latin America Market Size YoY Growth by Country

8.3.1 Mexico Sartans Market Size YoY Growth (2015-2026)

8.3.2 Brazil Sartans Market Size YoY Growth (2015-2026)

8.3.3 Argentina Sartans Market Size YoY Growth (2015-2026)

9 Middle East and Africa Sartans Market Size by Country (2015-2026)

9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)

9.1.1 Middle East and Africa Sartans Sales Market Share by Country (2015-2020)

9.1.2 Middle East and Africa Sartans Revenue Market Share by Country (2015-2020)

9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)

9.2.1 Middle East and Africa Sartans Sales Market Share by Country (2021-2026)

9.2.2 Middle East and Africa Sartans Revenue Market Share by Country (2021-2026)

9.3 Middle East and Africa Market Size YoY Growth by Country

9.3.1 Turkey Sartans Market Size YoY Growth (2015-2026)

9.3.2 Saudi Arabia Sartans Market Size YoY Growth (2015-2026)

9.3.3 U.A.E Sartans Market Size YoY Growth (2015-2026)



10 Company Profiles and Key Figures in Sartans Business

10.1 Pfizer

10.1.1 Pfizer Corporation Information

10.1.2 Pfizer Description, Business Overview and Total Revenue

10.1.3 Pfizer Sartans Sales, Revenue and Gross Margin (2015-2020)

10.1.4 Pfizer Sartans Products Offered

10.1.5 Pfizer Recent Development

10.2 Novartis

10.2.1 Novartis Corporation Information

10.2.2 Novartis Description, Business Overview and Total Revenue

10.2.3 Novartis Sartans Sales, Revenue and Gross Margin (2015-2020)

10.2.5 Novartis Recent Development

10.3 Merck

10.3.1 Merck Corporation Information

10.3.2 Merck Description, Business Overview and Total Revenue

10.3.3 Merck Sartans Sales, Revenue and Gross Margin (2015-2020)

10.3.4 Merck Sartans Products Offered

10.3.5 Merck Recent Development

10.4 Astra Zeneca

10.4.1 Astra Zeneca Corporation Information

10.4.2 Astra Zeneca Description, Business Overview and Total Revenue

10.4.3 Astra Zeneca Sartans Sales, Revenue and Gross Margin (2015-2020)

10.4.4 Astra Zeneca Sartans Products Offered

10.4.5 Astra Zeneca Recent Development

10.5 Jhonson and Johnson

10.5.1 Jhonson and Johnson Corporation Information

10.5.2 Jhonson and Johnson Description, Business Overview and Total Revenue

10.5.3 Jhonson and Johnson Sartans Sales, Revenue and Gross Margin (2015-2020)

10.5.4 Jhonson and Johnson Sartans Products Offered

10.5.5 Jhonson and Johnson Recent Development

10.6 Eli Lilly

10.6.1 Eli Lilly Corporation Information

10.6.2 Eli Lilly Description, Business Overview and Total Revenue

10.6.3 Eli Lilly Sartans Sales, Revenue and Gross Margin (2015-2020)

10.6.4 Eli Lilly Sartans Products Offered

10.6.5 Eli Lilly Recent Development

10.7 Sanofi

10.7.1 Sanofi Corporation Information

10.7.2 Sanofi Description, Business Overview and Total Revenue

10.7.3 Sanofi Sartans Sales, Revenue and Gross Margin (2015-2020)

10.7.4 Sanofi Sartans Products Offered

10.7.5 Sanofi Recent Development

10.8 Bristol-Myers Squibb

10.8.1 Bristol-Myers Squibb Corporation Information

10.8.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue

10.8.3 Bristol-Myers Squibb Sartans Sales, Revenue and Gross Margin (2015-2020)

10.8.4 Bristol-Myers Squibb Sartans Products Offered

10.8.5 Bristol-Myers Squibb Recent Development

10.9 Bayer

10.9.1 Bayer Corporation Information

10.9.2 Bayer Description, Business Overview and Total Revenue

10.9.3 Bayer Sartans Sales, Revenue and Gross Margin (2015-2020)

10.9.4 Bayer Sartans Products Offered

10.9.5 Bayer Recent Development

10.10 GSK

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Sartans Product Category, Application and Specification

10.10.3 GSK Sartans Sales, Revenue, Price and Gross Margin (2015-2020)

10.10.4 Main Business Overview

10.10.5 GSK Recent Development

10.11 Teva Pharmaceutical

10.11.1 Teva Pharmaceutical Corporation Information

10.11.2 Teva Pharmaceutical Description, Business Overview and Total Revenue

10.11.3 Teva Pharmaceutical Sartans Sales, Revenue and Gross Margin (2015-2020)

10.11.4 Teva Pharmaceutical Sartans Products Offered

10.11.5 Teva Pharmaceutical Recent Development



11 Sartans Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Sartans Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Sartans Industrial Chain Analysis

11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis

11.4.1 Market Opportunities and Drivers

11.4.2 Market Challenges

11.4.3 Market Risks

11.4.4 Porter’s Five Forces Analysis



12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Distributors

12.3 Downstream Customers



13 Research Findings and Conclusion



14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Author Details

14.4 Disclaimer